• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗 COVID-19 的治疗药物:临床证据。

Therapeutic Agents Against COVID-19 with Clinical Evidence.

机构信息

Department of Pharmacology, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

出版信息

Curr Pharm Des. 2021;27(13):1608-1617. doi: 10.2174/1381612827666210114150951.

DOI:10.2174/1381612827666210114150951
PMID:33459226
Abstract

Over 57 million people have been confirmed to have coronavirus disease 2019 (COVID-19) worldwide. Although several drugs have shown potential therapeutic effects, there is no specific drug against COVID-19. In this review, we summarized potential therapeutic agents against COVID-19 with clinical evidence, including antiviral agents, anti-cytokine storm syndrome agents, and vaccines, as well as other drugs. In addition, we briefly discussed their effects on COVID-19, which will contribute to developing treatment plans.

摘要

全球已确认超过 5700 万人感染 2019 冠状病毒病(COVID-19)。尽管已有几种药物显示出潜在的治疗效果,但针对 COVID-19 仍没有特效药物。本综述总结了具有临床证据的 COVID-19 潜在治疗药物,包括抗病毒药物、抗细胞因子风暴综合征药物和疫苗,以及其他药物。此外,我们还简要讨论了它们对 COVID-19 的作用,这将有助于制定治疗方案。

相似文献

1
Therapeutic Agents Against COVID-19 with Clinical Evidence.抗 COVID-19 的治疗药物:临床证据。
Curr Pharm Des. 2021;27(13):1608-1617. doi: 10.2174/1381612827666210114150951.
2
Recent Advances on Drugs and Vaccines for COVID-19.新冠病毒药物和疫苗的最新进展
Inquiry. 2021 Jan-Dec;58:469580211055630. doi: 10.1177/00469580211055630.
3
Drug Discovery Strategies for SARS-CoV-2.针对 SARS-CoV-2 的药物研发策略。
J Pharmacol Exp Ther. 2020 Oct;375(1):127-138. doi: 10.1124/jpet.120.000123. Epub 2020 Jul 28.
4
An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.关于在疫情爆发情况下治疗新型冠状病毒(SARS-CoV-2)的新兴治疗和预防策略的循证系统评价。
J Basic Clin Physiol Pharmacol. 2020 Sep 14;31(6):jbcpp-2020-0113. doi: 10.1515/jbcpp-2020-0113.
5
Pathogenesis-directed therapy of 2019 novel coronavirus disease.针对 2019 新型冠状病毒病的发病机制导向治疗。
J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10.
6
Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2.治疗方法和疫苗方面的最新进展,以应对 COVID-19/SARS-CoV-2。
Hum Vaccin Immunother. 2020 Dec 1;16(12):3034-3042. doi: 10.1080/21645515.2020.1794685. Epub 2020 Aug 26.
7
COVID-19: Innovative Antiviral Drugs Required for Long-Term Prevention and Control of Coronavirus Diseases.COVID-19:用于长期预防和控制冠状病毒病的创新抗病毒药物。
Curr Med Chem. 2021;28(18):3554-3567. doi: 10.2174/0929867327666201027152400.
8
Anti-malarial Drugs are Not Created Equal for SARS-CoV-2 Treatment: A Computational Analysis Evidence.抗疟药物在 SARS-CoV-2 治疗中并非一概而论:一项计算分析证据。
Curr Pharm Des. 2021;27(10):1323-1329. doi: 10.2174/1381612826666201210092736.
9
Properties of Ethnomedicinal Plants and Their Bioactive Compounds: Possible Use for COVID-19 Prevention and Treatment.民族药用植物及其生物活性化合物的特性:在 COVID-19 预防和治疗中的可能用途。
Curr Pharm Des. 2021;27(13):1579-1587. doi: 10.2174/1381612826666201106092021.
10
COVID-19 cooling: Nanostrategies targeting cytokine storm for controlling severe and critical symptoms.COVID-19 降温:针对细胞因子风暴的纳米策略控制严重和危急症状。
Med Res Rev. 2024 Mar;44(2):738-811. doi: 10.1002/med.21997. Epub 2023 Nov 21.